Lumbard & Kellner, LLC

Position in HROW — Harrow, Inc.

CIK 1602476 HOLLIS, NH

Position in HROW

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,122,590

-$1,204,698 QoQ

Shares Held

88,559

+0.3% QoQ

Ownership

0.238%

of shares outstanding

% of Portfolio

1.78%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Lumbard & Kellner, LLC holds $9,323,761 across 3 Drug Manufacturers - Specialty & Generic names. HROW ranks #2 (33.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ETON	Eton Pharmaceuticals, Inc.	175,911	$4,341,483
2	HROW	Harrow, Inc. This page	88,559	$3,122,590
3	ALKS	Alkermes plc.	52,593	$1,859,688

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,122,590	88,559	+0.3%	Shares	Sole	2026-05-15
2025-12-31	$4,327,288	88,312	-0.6%	Shares	Sole	2026-02-03
2025-09-30	$4,281,033	88,855	—	Shares	Sole	2025-11-12
No filing history on record for this holder in this stock.